Exciva

Heidelberg, Germany · Founded 2015 · Privately Held (backing)

Developer of antitussive medication designed to address both the neurological and psychological aspects of behavioral and psychological symptoms. Exciva is based in Heidelberg, Germany and was founded in 2015. Its last reported valuation was $16.4 million in Oct 2021. It has raised $70.1 million.

Last reported valuation

$16.4M

Oct 2026

Priced at

—

Total raised

$70.1M

Last round

—

How much has Exciva raised?

$70.1Macross 0 recorded rounds

Free account

More of Exciva with a free account

·Watch Exciva: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Exciva investors

9 investors are on record for Exciva, including EQT Life Sciences, Modi Ventures, Andera Partners and LBBW Venture Capital.

For fundraisers

Raising for a company like Exciva?

9 investors have backed Exciva.

See all 9 investors →

Frequently asked about Exciva

How much has Exciva raised?: Exciva has raised $70.1M in total across 0 recorded funding rounds.